Literature DB >> 26870336

CXC chemokine receptor 7 expression in cervical intraepithelial neoplasia.

Tian Tang1, Qingjie Xia2, Mingrong Xi1.   

Abstract

Cervical intraepithelial neoplasia (CIN), also known as transformation and dysplasia of cervical intraepithelial cells, is the precancerous lesion of squamous cell carcinoma. CXC chemokine receptor 7 (CXCR7) has been indicated in tumor development and metastasis of multiple malignancies or precancerous lesion. However, the protein expression and function of CXCR7 in different stages of human CIN remains unclear. The present study examined CXCR7 protein expression in cervical tissue samples from 34 patients, including 7 patients with normal cervical tissues (negative control), 10 patients with stage I of CIN (CIN I), 8 patients with CIN II and 9 patients with CIN III. Receiver operating characteristic curves (ROC) were established to evaluate the prognostic value of CXCR7 in differentiating various stages of CIN. Immunohistochemical staining showed that protein expression of CXCR7 was higher in CIN tissues compared with the normal cervical epithelium (P<0.05). High-grade CIN tissues expressed a higher level of CXCR7 compared to low-grade samples. The ROC curve of integral optical density analysis showed that CXCR7 could discriminate CIN I-III from normal cervical epithelium with 88.9% sensitivity and 71.4% specificity, and CIN II-III from the negative control and CIN I with 92.7% sensitivity and 50.0% specificity. ROC curve of area analysis also showed that CXCR7 could discriminate CIN I-III from normal cervical epithelium with 70.4% sensitivity and 100.0% specificity, and CIN II-III from the negative control and CIN I with 50.0% sensitivity and 90.0% specificity. An increase in CXCR7 expression may represent a novel predictor of CIN. The wide expression of CXCR7 in CIN also supports the assumption that CXCR7 plays a role in precancerous lesion progression, as well as proliferation, migration and angiogenesis.

Entities:  

Keywords:  CXC chemokine receptor 7; cervical intraepithelial neoplasia; immunohistochemistry; receiver operating characteristics curve analysis

Year:  2015        PMID: 26870336      PMCID: PMC4726869          DOI: 10.3892/br.2015.529

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  17 in total

Review 1.  An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology.

Authors:  Kirsten Hattermann; Rolf Mentlein
Journal:  Ann Anat       Date:  2012-12-08       Impact factor: 2.698

2.  Role of CXCR7 and effects on CXCL12 in SiHa cells and upregulation in cervical squamous cell carcinomas in Uighur women.

Authors:  Shajidai Kurban; Mikrban Tursun; Gulinar Kurban; Ayshamgul Hasim
Journal:  Asian Pac J Cancer Prev       Date:  2014

3.  Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.

Authors:  Florian Gebauer; Michael Tachezy; Katharina Effenberger; Katharina von Loga; Hilke Zander; Alexander Marx; Jussuf T Kaifi; Guido Sauter; Jakob R Izbicki; Maximilian Bockhorn
Journal:  J Surg Oncol       Date:  2011-04-25       Impact factor: 3.454

4.  Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells.

Authors:  Ke Zheng; Hong-Yuan Li; Xin-Liang Su; Xiao-Yi Wang; Tian Tian; Fan Li; Guo-Sheng Ren
Journal:  J Exp Clin Cancer Res       Date:  2010-04-11

5.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.

Authors:  Zhenhua Miao; Kathryn E Luker; Bretton C Summers; Rob Berahovich; Mahaveer S Bhojani; Alnawaz Rehemtulla; Celina G Kleer; Jeffrey J Essner; Aidas Nasevicius; Gary D Luker; Maureen C Howard; Thomas J Schall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

Review 6.  Cervical Intraepithelial Neoplasia (CIN) in pregnancy: the state of the art.

Authors:  M Origoni; S Salvatore; A Perino; G Cucinella; M Candiani
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014       Impact factor: 3.507

7.  CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients.

Authors:  M Schrevel; R Karim; N T ter Haar; S H van der Burg; J B M Z Trimbos; G J Fleuren; A Gorter; E S Jordanova
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

8.  CXCR7 protein expression in human adult brain and differentiated neurons.

Authors:  Saori Shimizu; Michael Brown; Rajarshi Sengupta; Mark E Penfold; Olimpia Meucci
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

9.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.

Authors:  Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

10.  The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.

Authors:  Jianhua Wang; Yusuke Shiozawa; Jincheng Wang; Yu Wang; Younghun Jung; Kenneth J Pienta; Rohit Mehra; Robert Loberg; Russell S Taichman
Journal:  J Biol Chem       Date:  2007-12-05       Impact factor: 5.486

View more
  2 in total

1.  N-Butylphthalide Alleviates Blood-Brain Barrier Impairment in Rats Exposed to Carbon Monoxide.

Authors:  Mingjun Bi; Mingwei Zhang; Dadong Guo; Weikang Bi; Bin Liu; Yong Zou; Qin Li
Journal:  Front Pharmacol       Date:  2016-10-26       Impact factor: 5.810

2.  CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1.

Authors:  Danyang Zhao; Wenban Qin; Chuanxiang Zhao; Jianxiong Long; Mujun Li
Journal:  Cancer Manag Res       Date:  2019-12-09       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.